CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,177 enrolled
Drug / intervention
Vareniclinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01104636
NCT01104636N/ACompleted
CompareCT.gov

"VIBRATIONS": Varenicline In Patients Ambitioned To Terminate Smoking - A Non-Interventional Study

Pfizer·observational·Posted Apr 15, 2010·Updated Mar 2, 2012

In Brief

An observational study evaluating Varenicline for Smoking Cessation. Completed, enrolled 1,177 participants.

Detailed Summary

The aim of this study is to determine the success rates for stopping smoking with varenicline in Germany. The main measure of success will be continuous abstinence from smoking (not a single puff) in the last week of the standard 12 week treatment period. Additional information will be gathered regarding prescribing practices in Germany, smoking history, reasons why smokers quit smoking and re-start smoking, smoking related illnesses and the tolerability of varenicline.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 15, 2010
Enrollment StartMay 1, 2010
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 16.2 years ago

Interventions

Vareniclinedrug

varenicline tablets prescribed as per local German SmPC for 12 weeks duration